Meet the 3 best financial stocks for your portfolio

Magellan Financial Group Ltd (ASX:MFG) and Challenger Ltd (ASX:CGF) are among the best.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In the capitalist world there's no escaping the fact that if you control sufficient amounts of capital making money is easier than drinking a glass of water.

The more capital money managers amass under management the higher their revenues, as fees are generally a fixed percentage of funds under management.

Staff costs are usually their biggest expense and the best money managers are scalable in that they are able to grow revenues far faster than staff costs.

Generally they will boast far lower cost to income ratios than their peers, which indicates good management, higher returns on equity and a high-performing pool of staff well incentivised to succeed for themselves and shareholders.

Below I explain why the following three businesses exhibit these credentials and are my pick of the financials for long-term growth and income.

Challenger Ltd (ASX: CGF) recently reduced its cost to income ratio to 33.8% which is a record low and impressive number given its size and fact it has two operating divisions in funds management and the provision of annuities.

The group appears to have an excellent control on costs and has a strong tailwind as Australia's ageing population demands annuity products that Challenger is the market leader in providing. Annuity sales for the first quarter of 2016 were up 12% over the prior corresponding period and the group ticks the boxes as a long-term growth prospect. The stock is up 24% in 2015 and I expect will enjoy a strong 2016.

Magellan Financial Group Ltd (ASX: MFG) is my particular favourite with an astonishingly low cost to income ratio of just 20.6% for the last financial year. This is a reflection of the fact it's a founder led startup still able to handpick staff despite growing at a gangbusters rate to now manage more than $38 billion in funds under management.

Compare Magellan's cost to income ratio with that of Perpetual Limited (ASX: PPT) at 63% – even after Perpetual just undertook one of the most radical cost-cutting programs in the history of Australian financial services, also suffering FUM outflows again, Perpetual looks a sell.

However, Magellan continues to grow FUM and re-invest surplus capital to compound growth at impressive returns. Selling for $21.97 this stock ticks all the boxes and equity markets permitting I expect it will continue to outperform in 2016.

Macquarie Group Ltd (ASX: MQG) is accelerating its focus away from market sensitive activities to retail banking, wealth management and corporate lending as the core of its business. Recent evidence of this shift include two recent multi-billion dollar acquisitions to increase its exposure in aircraft leasing and car dealer financing.

The shift away from performance-based trading activities that are sensitive to financial market conditions also means it has the opportunity to reduce its high cost to income ratio. This is unlikely to be popular with staff, but looks probable over the long term and should provide subtle support to earnings per share growth over the years.

Macquarie also generates the majority of its income overseas and given earnings are now less leveraged to big market shocks, I expect it will continue to outperform in 2016 and beyond.

Motley Fool contributor Tom Richardson owns shares of Macquarie Group Limited and Magellan Financial Group. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. You can find Tom on Twitter @tommyr345 We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »